AU2018215785B2 - Materials and methods for delivering nucleic acids to cochlear and vestibular cells - Google Patents

Materials and methods for delivering nucleic acids to cochlear and vestibular cells Download PDF

Info

Publication number
AU2018215785B2
AU2018215785B2 AU2018215785A AU2018215785A AU2018215785B2 AU 2018215785 B2 AU2018215785 B2 AU 2018215785B2 AU 2018215785 A AU2018215785 A AU 2018215785A AU 2018215785 A AU2018215785 A AU 2018215785A AU 2018215785 B2 AU2018215785 B2 AU 2018215785B2
Authority
AU
Australia
Prior art keywords
harmonin
mice
promoter
anc80
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018215785A
Other languages
English (en)
Other versions
AU2018215785A1 (en
AU2018215785A9 (en
Inventor
Yukako ASAI
Gwenaelle GELEOC
Jeffrey Holt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of AU2018215785A1 publication Critical patent/AU2018215785A1/en
Publication of AU2018215785A9 publication Critical patent/AU2018215785A9/en
Priority to AU2023214288A priority Critical patent/AU2023214288A1/en
Application granted granted Critical
Publication of AU2018215785B2 publication Critical patent/AU2018215785B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2018215785A 2017-02-06 2018-02-06 Materials and methods for delivering nucleic acids to cochlear and vestibular cells Active AU2018215785B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2023214288A AU2023214288A1 (en) 2017-02-06 2023-08-09 Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762455197P 2017-02-06 2017-02-06
US62/455,197 2017-02-06
PCT/US2018/017104 WO2018145111A1 (en) 2017-02-06 2018-02-06 Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023214288A Division AU2023214288A1 (en) 2017-02-06 2023-08-09 Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Publications (3)

Publication Number Publication Date
AU2018215785A1 AU2018215785A1 (en) 2019-08-22
AU2018215785A9 AU2018215785A9 (en) 2019-09-26
AU2018215785B2 true AU2018215785B2 (en) 2023-08-31

Family

ID=63040112

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018215785A Active AU2018215785B2 (en) 2017-02-06 2018-02-06 Materials and methods for delivering nucleic acids to cochlear and vestibular cells
AU2023214288A Pending AU2023214288A1 (en) 2017-02-06 2023-08-09 Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2023214288A Pending AU2023214288A1 (en) 2017-02-06 2023-08-09 Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Country Status (7)

Country Link
US (2) US11730827B2 (enExample)
EP (1) EP3576696A4 (enExample)
JP (2) JP2020508648A (enExample)
CN (1) CN111698975A (enExample)
AU (2) AU2018215785B2 (enExample)
CA (1) CA3052704A1 (enExample)
WO (1) WO2018145111A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3510161A4 (en) 2016-08-23 2020-04-22 Akouos, Inc. COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING DEFICIENCY IN A HUMAN SUBJECT
DE102018103924A1 (de) * 2018-02-21 2019-08-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Gentherapeutische Behandlung von Schwerhörigkeit
JP7430652B2 (ja) 2018-03-05 2024-02-13 ザ チルドレンズ メディカル センター コーポレーション 蝸牛および前庭細胞に核酸を送達するための組成物および方法
US11660353B2 (en) 2018-04-27 2023-05-30 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
JP7331011B2 (ja) 2018-04-27 2023-08-22 デシベル セラピューティクス インコーポレイテッド ミオシン１５プロモーター及びその使用
EP3856227A4 (en) * 2018-09-27 2022-07-06 Akouos, Inc. A method for treating an auditory neuropathy spectrum disorder
US20220096658A1 (en) * 2018-12-21 2022-03-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Svcs. Adeno-associated viruses and their uses for inner ear therapy
WO2020163743A1 (en) 2019-02-08 2020-08-13 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
CA3129422A1 (en) 2019-02-08 2020-08-13 Decibel Therapeutics, Inc. Myosin 15 promoters and uses thereof
EP3959324B1 (en) * 2019-04-26 2025-09-17 President and Fellows of Harvard College Aav vectors encoding mini-pcdh15 and uses thereof
US20220396806A1 (en) * 2019-07-26 2022-12-15 Akouos, Inc. Methods of treating hearing loss using a secreted target protein
EP4055175A4 (en) * 2019-11-04 2023-11-29 Decibel Therapeutics, Inc. Cochlear inner hair cell promoters and uses thereof
WO2021091950A1 (en) * 2019-11-04 2021-05-14 Decibel Therapeutics, Inc. Vestibular supporting cell promoters and uses thereof
CN113840915A (zh) * 2020-01-24 2021-12-24 美利坚合众国, 由健康及人类服务部部长代表 腺相关病毒及其用于内耳疗法的用途
WO2021168362A1 (en) 2020-02-21 2021-08-26 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
WO2022129543A1 (en) * 2020-12-18 2022-06-23 Institut Pasteur Gene therapy for treating usher syndrome
CN114762733B (zh) * 2021-01-15 2025-03-18 中国科学院脑科学与智能技术卓越创新中心 耳蜗外毛细胞特异性顺式调节元件及其应用
KR102751019B1 (ko) * 2021-03-03 2025-01-09 연세대학교 산학협력단 Kcnq4 유전자 교정용 가이드 rna 및 이를 포함하는 난청 치료용 조성물
US20250114480A1 (en) 2022-01-25 2025-04-10 Bridgebio Gene Therapy Research, Inc. Gene therapy for genetic hearing loss
WO2024239226A1 (zh) * 2023-05-23 2024-11-28 苏州星奥拓维生物技术有限公司 耳蜗毛细胞特异性启动子及其用途
CN119061007A (zh) * 2023-06-02 2024-12-03 苏州星奥拓维生物技术有限公司 耳蜗支持细胞基因治疗和再生的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673634B2 (en) * 2003-11-13 2014-03-18 Massachusetts Eye & Ear Infirmary Method for the treatment of hearing loss
WO2011075838A1 (en) 2009-12-21 2011-06-30 Audigen Inc. Method of treating or preventing hearing loss
KR100990160B1 (ko) * 2010-03-15 2010-10-29 도태환 기전력 안정화 영구자석 발전기
JP6552511B2 (ja) * 2013-10-11 2019-07-31 マサチューセッツ アイ アンド イヤー インファーマリー 祖先ウイルス配列を予測する方法およびその使用
BR112016013201B1 (pt) * 2013-12-12 2023-01-31 The Broad Institute, Inc. Uso de uma composição compreendendo um sistema crispr-cas no tratamento de uma doença genética ocular
JP6990182B2 (ja) * 2015-12-11 2022-02-15 マサチューセッツ アイ アンド イヤー インファーマリー 蝸牛および前庭細胞に核酸を送達するための材料および方法
US20190038778A1 (en) 2016-02-05 2019-02-07 The General Hospital Corporation Hybrid System for Efficient Gene Delivery to Cells of the Inner Ear
WO2018017834A1 (en) * 2016-07-21 2018-01-25 The Regents Of The University Of California Methods for inducing stereocilia on hair cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Géléoc, G.G.S., et al., "Gene Therapy Restores Auditory and Vestibular Function in a Mouse Model of Usher Syndrome, Type I", Inner Ear Biology, 2016, abstract S7 *

Also Published As

Publication number Publication date
WO2018145111A9 (en) 2019-08-29
EP3576696A4 (en) 2020-09-16
CA3052704A1 (en) 2018-08-09
AU2023214288A1 (en) 2023-11-30
EP3576696A1 (en) 2019-12-11
US20230330268A1 (en) 2023-10-19
CN111698975A (zh) 2020-09-22
WO2018145111A1 (en) 2018-08-09
JP2023036921A (ja) 2023-03-14
JP2020508648A (ja) 2020-03-26
JP7601916B2 (ja) 2024-12-17
US11730827B2 (en) 2023-08-22
AU2018215785A1 (en) 2019-08-22
US20190351072A1 (en) 2019-11-21
AU2018215785A9 (en) 2019-09-26

Similar Documents

Publication Publication Date Title
US20230330268A1 (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
US12102692B2 (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
US12281313B2 (en) Compositions and methods for delivering nucleic acids to cochlear and vestibular cells
Pan et al. Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome type 1c
CN120899947A (zh) 用于治疗人受试者中非年龄相关的听力损害的组合物和方法
JP2023515072A (ja) ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
Ivanchenko et al. Cell-specific delivery of GJB2 restores auditory function in mouse models of DFNB1 deafness and mediates appropriate expression in NHP cochlea
HK40074395A (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
HK1262434B (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
HK40003977B (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells
WO2025166351A1 (en) Compositions and methods for hearing loss
HK40003977A (en) Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)